Clinical Trial Update: A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for AMG 337 in Asian subjects with stomach neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stomach Neoplasms

Drugs mentioned

• AMG 337

Snippet

Sponsor: Amgen | Conditions: Stomach Neoplasms | Phase 1, Phase 2 | Status: COMPLETED